$9.30
0.141.53%
Last update: 9:40 AM
15 minutes delayed
Comments
Loading...
Maravai LifeSciences (NASDAQ:MRVI) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Maravai LifeSciences (MRVI)?
The most recent guidance for Maravai LifeSciences (MRVI) was reported on November 7, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $-0.01 to $0.01, compared to the estimated EPS of $0.06. Additionally, Maravai LifeSciences forecasted revenue between $0.28B and $0.28B for the quarter.
Browse guidance and forecast on all stocks.